Date  |
|
| Dec 09, 2020 |
Vivos Inc Completes Surrogate Lymph Node Testing Using Mouse Spleen Injections Demonstrating Uniform Perfusion and Stability |
| Dec 07, 2020 |
Vivos Inc to Present at The 13th Annual LD Micro Main Event Conference December 15, 2020 11:00 AM Eastern Standard Time |
| Dec 01, 2020 |
Vivos Inc Extends it Intellectual Property Protection |
| Nov 20, 2020 |
Vivos Inc Applies for Breakthrough Device Designation for Radiogel™ |
| Sep 03, 2020 |
Vivos Inc Initiates IsoPet Therapy of Horses – Addressing Unmet Need for the Treatment of Equine Tumors |
| Sep 01, 2020 |
Vivos Inc to Present at The LD 500 Virtual Conference |
| Aug 26, 2020 |
Vivos Inc Provides Update on Initial Indication for Use for RadioGelTM Therapy |
| Jul 30, 2020 |
Vivos Inc Reports Additional IsoPet Therapies |
| Jul 22, 2020 |
Vivos Inc Receives Grant of Protection for RadioGel™ Therapy in China |
| Jun 24, 2020 |
Vivos Inc Achieves Important Radiogel™ Development Milestones |